rs75152012
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000477.7(ALB):βc.228_229delβ(p.Val78CysfsTer2) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000421 in 1,613,748 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.000046 ( 0 hom., cov: 32)
Exomes π: 0.000042 ( 0 hom. )
Consequence
ALB
NM_000477.7 frameshift
NM_000477.7 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.01
Genes affected
ALB (HGNC:399): (albumin) This gene encodes the most abundant protein in human blood. This protein functions in the regulation of blood plasma colloid osmotic pressure and acts as a carrier protein for a wide range of endogenous molecules including hormones, fatty acids, and metabolites, as well as exogenous drugs. Additionally, this protein exhibits an esterase-like activity with broad substrate specificity. The encoded preproprotein is proteolytically processed to generate the mature protein. A peptide derived from this protein, EPI-X4, is an endogenous inhibitor of the CXCR4 chemokine receptor. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 4-73406718-CAT-C is Pathogenic according to our data. Variant chr4-73406718-CAT-C is described in ClinVar as [Pathogenic]. Clinvar id is 156319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALB | NM_000477.7 | c.228_229del | p.Val78CysfsTer2 | frameshift_variant | 3/15 | ENST00000295897.9 | NP_000468.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALB | ENST00000295897.9 | c.228_229del | p.Val78CysfsTer2 | frameshift_variant | 3/15 | 1 | NM_000477.7 | ENSP00000295897 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152182Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
7
AN:
152182
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251180Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135802
GnomAD3 exomes
AF:
AC:
11
AN:
251180
Hom.:
AF XY:
AC XY:
8
AN XY:
135802
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461566Hom.: 0 AF XY: 0.0000495 AC XY: 36AN XY: 727092
GnomAD4 exome
AF:
AC:
61
AN:
1461566
Hom.:
AF XY:
AC XY:
36
AN XY:
727092
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74350
GnomAD4 genome
AF:
AC:
7
AN:
152182
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74350
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 19, 2023 | Common recurrent variant located in a hypermutable region and also known as the Kayseri variant, accounting for up to 1/3 of patients with analbuminemia (Caridi et al., 2016; Caridi et al., 2018; Minchiotti et al., 2019); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 22227324, 20638375, 34426522, 29981851, 27346974, 34662886, 12028999) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 29, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 156319). This variant is also known as Kayseri and 2430_2431del. This premature translational stop signal has been observed in individual(s) with analbuminemia (PMID: 12028999, 18459107). This variant is present in population databases (rs75152012, gnomAD 0.02%). This sequence change creates a premature translational stop signal (p.Val78Cysfs*2) in the ALB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALB are known to be pathogenic (PMID: 12028999). - |
Analbuminemia Other:1
not provided, no classification provided | literature only | ClinVar Staff, National Center for Biotechnology Information (NCBI) | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at